Quarterly report pursuant to Section 13 or 15(d)

Licensing and Other Arrangements - Rezolute - Second and Third Amendments (Details)

v3.20.1
Licensing and Other Arrangements - Rezolute - Second and Third Amendments (Details)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2019
USD ($)
Jan. 30, 2019
USD ($)
Jan. 07, 2019
USD ($)
item
Apr. 03, 2018
USD ($)
Dec. 06, 2017
shares
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Aug. 31, 2019
USD ($)
item
Mar. 31, 2020
USD ($)
installment
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2020
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
Jun. 30, 2019
USD ($)
Licensing and other arrangements                                
Revenue from contracts with customers                 $ 500     $ 8,026        
Provision for bad debt                 1,409              
Rezolute | License Agreement and Common Stock Purchase Agreement                                
Licensing and other arrangements                                
Amount of Rezolute's common stock eligible to receive     $ 8,500       $ 8,500                  
Number of future cash payments upon closing of the qualified financing | item     5                          
Future cash payments upon closing of the qualified financing     $ 8,500                 8,500        
Percentage of net proceeds of each future financing upon closing of the qualified financing     15.00%                          
Gross proceeds received by third party from preferred stock financing   $ 25,000                            
Consideration received following qualified financing event   5,500                            
Reimbursable technology transfer expense received   $ 300   $ 300                        
Revenue from contracts with customers           $ 2,500         $ 6,000       $ 1,800  
Doubtful revenue reversal of future cash payments           $ 2,500   $ 3,600       $ 2,500        
Number of common stock financing events | item               2                
Early payment of unrecognized future cash payments               $ 3,400                
Unrecognized future cash payments                               $ 6,000
Future cash payments received $ 1,500               400 $ 1,000 $ 4,900          
Upfront consideration to incremental discount for future payment       0                        
Outstanding receivable                 800              
Contract assets                 0 0       $ 0    
Contract liabilities                 0 0       0    
Capitalized contract costs                 0 $ 0       $ 0    
Rezolute | License Agreement and Common Stock Purchase Agreement | Maximum                                
Licensing and other arrangements                                
Future cash payments of revenue recognized     $ 8,500                          
Rezolute | License Agreement                                
Licensing and other arrangements                                
Reimbursable technology transfer expense received       $ 300                        
Revenue from contracts with customers                 0              
Future cash payments of revenue recognized                 $ 2,600              
Number of quarterly payments | installment                 7              
Payment period following closing of Qualified Financing                 15 days              
Provision for bad debt                 $ 1,400              
Rezolute | Common Stock Purchase Agreement                                
Licensing and other arrangements                                
Number of Rezolute's shares Company has right and option to sell if Rezolute does not list common stock shares on national exchange | shares         5,000,000                 5,000,000    
Rezolute | Common Stock Purchase Agreement | Forecast | Maximum                                
Licensing and other arrangements                                
Number of Rezolute's shares Company has right and option to sell if Rezolute does not list common stock shares on national exchange | shares                         2,500,000